Drug Research - Search News

FDA fast-tracks psychedelic drug research

FDA fast-tracks psychedelic drug research following Trump executive order

The FDA announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness.

· 1d · on MSN

FDA fast-tracking psychedelic drug research after Trump order

· 1d

FDA grants quick review for 3 psychedelic drug trials

· 1d

FDA Plans Ultra-Fast Review of Three Psychedelic Drugs Following Trump Directive

The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the latest indication o...

· 23h

Psychedelics are coming. Are we ready?

Scientific American · 1d

RFK, Jr., puts psychedelics on fast track to FDA review and approval

· 1d

FDA moves to fast-track review of psilocybin and methylone for mental health

The US Food and Drug Administration on Friday issued national priority vouchers to three companies studying these psychedelic-based medicines: psilocybin, the active ingredient in “magic mushrooms,” f...

STAT · 1d

FDA to speed up review of three psychedelics as mental health treatments

Marijuana Moment · 1d

Federal Officials Announce Plan For ‘Accelerating’ Access To Psychedelics For Patients With Mental Health Conditions Following Trump’s Order

9don MSN

Federal research into psychedelic drug Ibogaine to treat PTSD may soon be reality

This naturally occurring substance, derived from an African shrub, has been used to treat PTSD, brain trauma, depression, addiction and other disorders.

7don MSN

Joe Rogan joins Trump to sign order allowing psychedelic drug research

Podcaster Joe Rogan joined President Trump and others in the Oval Office on Saturday as he signed an executive order accelerating research for certain psychedelic drugs used to treat mental health disorders.

Washington Examiner

News outlets circulated drug research from nonprofit group without disclosing its pharmaceutical industry ties

A small and financially opaque drug research nonprofit group based in Ohio has managed to get its research cited extensively in high-prestige publications such as the New York Times, Wall Street Journal, and Reuters. A Washington Examiner review of public ...

Yahoo

FDA will drop two-study requirement for new drug approvals, aiming to speed access

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Marty Makary, commissioner of the Food and Drug Administration speaks at an event on addiction recovery in the Oval Office of the White House, Thursday, Jan. 29, 2026, in Washington ...

Trump reclassifies state-licensed medical marijuana as a less-dangerous drug in a historic shift

A cannabis industry group calls President Donald Trump’s reclassification of state-licensed medical marijuana as a less-dangerous drug “the most significant federal advancement in cannabis policy” in